These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 27975230

  • 41. Feature selection and nearest centroid classification for protein mass spectrometry.
    Levner I.
    BMC Bioinformatics; 2005 Mar 23; 6():68. PubMed ID: 15788095
    [Abstract] [Full Text] [Related]

  • 42. Combining bioinformatics and MS-based proteomics: clinical implications.
    Acosta-Martin AE, Lane L.
    Expert Rev Proteomics; 2014 Jun 23; 11(3):269-84. PubMed ID: 24720436
    [Abstract] [Full Text] [Related]

  • 43. Data mining methods in Omics-based biomarker discovery.
    Zhang F, Chen JY.
    Methods Mol Biol; 2011 Jun 23; 719():511-26. PubMed ID: 21370100
    [Abstract] [Full Text] [Related]

  • 44. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
    Wu HY, Goan YG, Chang YH, Yang YF, Chang HJ, Cheng PN, Wu CC, Zgoda VG, Chen YJ, Liao PC.
    J Proteome Res; 2015 Aug 07; 14(8):3039-50. PubMed ID: 26120931
    [Abstract] [Full Text] [Related]

  • 45. Revisiting biomarker discovery by plasma proteomics.
    Geyer PE, Holdt LM, Teupser D, Mann M.
    Mol Syst Biol; 2017 Sep 26; 13(9):942. PubMed ID: 28951502
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Proteomic diagnosis competition: design, concepts, participants and first results.
    Mertens BJ.
    J Proteomics; 2009 Jul 21; 72(5):785-90. PubMed ID: 19375529
    [Abstract] [Full Text] [Related]

  • 48. Evaluation of strong cation exchange versus isoelectric focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry.
    Slebos RJ, Brock JW, Winters NF, Stuart SR, Martinez MA, Li M, Chambers MC, Zimmerman LJ, Ham AJ, Tabb DL, Liebler DC.
    J Proteome Res; 2008 Dec 21; 7(12):5286-94. PubMed ID: 18939861
    [Abstract] [Full Text] [Related]

  • 49. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.
    Shi T, Su D, Liu T, Tang K, Camp DG, Qian WJ, Smith RD.
    Proteomics; 2012 Apr 21; 12(8):1074-92. PubMed ID: 22577010
    [Abstract] [Full Text] [Related]

  • 50. A data review and re-assessment of ovarian cancer serum proteomic profiling.
    Sorace JM, Zhan M.
    BMC Bioinformatics; 2003 Jun 09; 4():24. PubMed ID: 12795817
    [Abstract] [Full Text] [Related]

  • 51. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H, Schulte I, Hess R, Menzel C, Kellmann M, Mohring T, Schulz-Knappe P.
    Proteomics; 2005 Aug 09; 5(13):3414-22. PubMed ID: 16038021
    [Abstract] [Full Text] [Related]

  • 52. Utilizing human blood plasma for proteomic biomarker discovery.
    Jacobs JM, Adkins JN, Qian WJ, Liu T, Shen Y, Camp DG, Smith RD.
    J Proteome Res; 2005 Aug 09; 4(4):1073-85. PubMed ID: 16083256
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Plasma/Serum Proteomics based on Mass Spectrometry.
    Zhu Y.
    Protein Pept Lett; 2024 Aug 09; 31(3):192-208. PubMed ID: 38869039
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Identification of biomarkers from mass spectrometry data using a "common" peak approach.
    Fushiki T, Fujisawa H, Eguchi S.
    BMC Bioinformatics; 2006 Jul 26; 7():358. PubMed ID: 16869977
    [Abstract] [Full Text] [Related]

  • 57. Coherent pipeline for biomarker discovery using mass spectrometry and bioinformatics.
    Al-Shahib A, Misra R, Ahmod N, Fang M, Shah H, Gharbia S.
    BMC Bioinformatics; 2010 Aug 26; 11():437. PubMed ID: 20796299
    [Abstract] [Full Text] [Related]

  • 58. Integrative analysis to select cancer candidate biomarkers to targeted validation.
    Kawahara R, Meirelles GV, Heberle H, Domingues RR, Granato DC, Yokoo S, Canevarolo RR, Winck FV, Ribeiro AC, Brandão TB, Filgueiras PR, Cruz KS, Barbuto JA, Poppi RJ, Minghim R, Telles GP, Fonseca FP, Fox JW, Santos-Silva AR, Coletta RD, Sherman NE, Paes Leme AF.
    Oncotarget; 2015 Dec 22; 6(41):43635-52. PubMed ID: 26540631
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.